Reuters Health Report

Click to View in Browser 09/16/2014 Obama to deploy 3,000 troops as Ebola crisis worsens WASHINGTON (Reuters) - The United States announced on Tuesday it will send 3,000 troops to help tackle the Ebola outbreak as part of a ramped-up plan, including a major deployment in Liberia, the country where the epidemic is spiraling fastest out of control. FDA approves AstraZeneca, Nektar constipation drug (Reuters) - The U.S. Food and Drug Administration approved an oral therapy to treat opioid-induced constipation developed by Nektar Therapeutics and AstraZeneca Plc. Northwest Bio drug gets first slot under UK early access scheme LONDON (Reuters) - An experimental Northwest Biotherapeutics  drug for inoperable tumors is the first medicine to have been selected for fast-track designation under a new early access scheme in Britain. Merck KGaA agrees to market Lupin drugs in emerging countries FRANKFURT (Reuters) - German drugmaker Merck KGaA said it struck a deal with Lupin Limited to market some of the Indian drugmaker's cardiovascular and diabetes treatments in emerging markets. Switzerland takes on its top drugmakers in price row ZURICH (Reuters) - Switzerland, home to the world's two biggest drugmakers, might be expected to give them an easy ride. But Roche and Novartis are finding no immunity in their home market from a European-wide price squeeze. Study shows Novo's new diabetes drug effective and safe for children COPENHAGEN (Reuters) - Novo Nordisk's new long-acting insulin Tresiba has been shown to be effective and safe for long-term use in children and young adults with type 1 diabetes, according to new data from a late-stage trial presented on Tuesday. World hunger easing but 1 in 9 people undernourished: food agencies ROME (Reuters) - The number of hungry people in the world has fallen sharply over the past decade but 805 million, or one in nine of the global population, still do not have enough to eat, three U.N. food and agriculture agencies said on Tuesday. Exclusive: Two Apple medical trials shed light on how HealthKit will work SAN FRANCISCO (Reuters) - Two prominent U.S. hospitals are preparing to launch trials with diabetics and chronic disease patients using Apple Inc's HealthKit, offering a glimpse of how the iPhone maker's ambitious take on healthcare will work in practice. AstraZeneca gets up to $500 million from Lilly for Alzheimer's drug LONDON (Reuters) - AstraZeneca has signed a partnership deal with U.S. rival Eli Lilly that could earn the British company up to $500 million if a promising – but risky – experimental Alzheimer's drug proves successful. U.S. says 115,000 could lose Obamacare insurance over immigration WASHINGTON (Reuters) - The Obama administration on Monday said 115,000 people in 36 states could lose their private health insurance under Obamacare after Sept. 30, because of unresolved data problems involving their citizenship or immigration status. Related Video Wildfires rage across bone-dry California Wireless charging technology comes to Formula-E racing The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend